PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 16417988

Characterisation of laboratory-generated vancomycin intermediate resistant Staphylococcus aureus strains.

Pragya Bhateja·Kedar Purnapatre·Smita Dube·Tasneem Fatma·Ashok Rattan
View original source ↗Export metadata ↓

Abstract

Vancomycin has been the drug of choice for 30 years for the treatment of methicillin-resistant Staphylococcus aureus (MRSA). Emergence of decreased vancomycin susceptibility in MRSA strains presents a significant clinical problem with few therapeutic options. This study was performed to generate and characterise S. aureus strains with reduced susceptibility to vancomycin. Eighteen S. aureus strains were subjected to serial passaging on vancomycin to generate vancomycin intermediate resistant S. aureus (VISA) strains. Minimum inhibitory concentration (MIC) determination was performed for the parent and the passaged cultures with 13 different antibiotics. The strains were tested by the following five methods: simplified population analysis; CDC method; modified vancomycin agar screen; population analysis profile (PAP); and modified population analysis (PAP-area under the curve (AUC) ratio). Phenotypic changes such as doubling time, synergy with beta-lactam antibiotics and effect on norA efflux pumps were also studied for these strains. The result indicated that 8 VISA mutants (vancomycin MICs, 8-16 microg/mL) were generated in vitro from the 18 S. aureus strains. The CDC and modified agar methods proved to be the most sensitive and specific methods for detection of VISA strains. The PAP for all the VISA strains ranged from 12 microg/mL to > 16 microg/mL, with a PAP-AUC ratio of > 1.3. All mutants showed increased doubling time compared with their parent isolate. Synergism of the vancomycin and beta-lactam combinations was observed for all methicillin-resistant mutants. Upon acquisition of vancomycin resistance, a few mutants showed decreased oxacillin resistance. Two VISA strains were chosen for molecular characterisation of the mecA gene and one mutant showed genotypic changes with deletion of mecA. Loss of norA efflux pumps leading to fluoroquinolone sensitivity was also observed in four mutants.

Explore related subjects

LaboratoriesMicrobial Sensitivity TestsStaphylococcus aureusVancomycinVancomycin ResistanceJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Pragya Bhateja, Kedar Purnapatre, Smita Dube, Tasneem Fatma, Ashok Rattan. 2006-01-18. Characterisation of laboratory-generated vancomycin intermediate resistant Staphylococcus aureus strains.. https://doi.org/10.1016/j.ijantimicag.2005.10.008

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Laboratory-scale experiments applied to the design of a two-stage submerged combustion evaporation system.

To simulate a submerged combustion evaporation (SCE) process under laboratory conditions, this study conducted three kinds of indirect-heating evaporation experiments, including normal evaporation, vacuum evaporation, and gas-carrying evaporation experiments on mature municipal solid waste (MSW) landfill leachate. The results showed that the organic concentrations in terms of COD in condensates were always very high at the beginning, then decreased rapidly, and stabilized at a low level, which suggests that only the forepart of vapors need to be safely treated to control the discharge of organic pollutants. This study applied the process in developing a two-stage SCE system, which has been implemented for the treatment of biologically pretreated and concentrated leachate from Membrane Bioreactor (MBR) and Reverse Osmosis (RO) combined process in the Beishenshu MSW Landfill, Beijing, China. The result shows that the two-stage SCE system can successfully further concentrate refractory organic matter in concentrated leachate and remove volatile organics from the vapor.

Laboratories↗
PubMed2006

Testing equivalence between two laboratories or two methods using paired-sample analysis and interval hypothesis testing.

A modified interval hypothesis testing procedure based on paired-sample analysis is described, as well as its application in testing equivalence between two bioanalytical laboratories or two methods. This testing procedure has the advantage of reducing the risk of wrongly concluding equivalence when in fact two laboratories or two methods are not equivalent. The advantage of using paired-sample analysis is that the test is less confounded by the intersample variability than unpaired-sample analysis when incurred biological samples with a wide range of concentrations are included in the experiments. Practical aspects including experimental design, sample size calculation and power estimation are also discussed through examples.

Laboratories↗